80 related articles for article (PubMed ID: 19961930)
1. Pharmacokinetic interaction between liquiritigenin (LQ) and DDB: increased glucuronidation of LQ in the liver possibly due to increased hepatic blood flow rate by DDB.
Kang HE; Chung HJ; Kim HS; Lee JW; Lee MG
Eur J Pharm Sci; 2010 Jan; 39(1-3):181-9. PubMed ID: 19961930
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic interaction between oltipraz and dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate (DDB) after single intravenous and oral administration to rats.
Bae SK; Kim EJ; Chung SJ; Kim SG; Lee MG
J Pharm Pharmacol; 2003 Sep; 55(9):1241-9. PubMed ID: 14604467
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of liquiritigenin and its two glucuronides, M1 and M2, in rats with acute hepatitis induced by d-galactosamine/lipopolysaccharide or CCl(4).
Kang HE; Kim YW; Sohn SI; Baek SR; Lee JW; Kim SG; Lee I; Lee MG
Xenobiotica; 2010 Jun; 40(6):424-36. PubMed ID: 20350053
[TBL] [Abstract][Full Text] [Related]
4. Liquiritigenin, an aglycone of liquiritin in Glycyrrhizae radix, prevents acute liver injuries in rats induced by acetaminophen with or without buthionine sulfoximine.
Kim YW; Ki SH; Lee JR; Lee SJ; Kim CW; Kim SC; Kim SG
Chem Biol Interact; 2006 Jun; 161(2):125-38. PubMed ID: 16647697
[TBL] [Abstract][Full Text] [Related]
5. Liquiritigenin pharmacokinetics in a rat model of diabetes mellitus induced by streptozotocin: greater formation of glucuronides in the liver, especially M2, due to increased hepatic uridine 5'-diphosphoglucuronic acid level.
Kang HE; Sohn SI; Baek SR; Lee JW; Lee MG
Metabolism; 2010 Oct; 59(10):1472-80. PubMed ID: 20170928
[TBL] [Abstract][Full Text] [Related]
6. Contribution of a significant first-pass effect of dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate in the liver to its poor bioavailability in rats.
Yu KH; Lee YR; Ahn SH; Kim DD; Shim CK; Chung SJ
J Pharm Pharmacol; 2009 Sep; 61(9):1197-203. PubMed ID: 19703369
[TBL] [Abstract][Full Text] [Related]
7. The metabolism and excretion of 2-methylaminoethoxycarbonyl-4,4'-dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2'-carboxylic acid (DDB-S) in rats and human.
Yoo HH; Son J; Lee J; Kim NS; Shin M; Kang MJ; Kim DH
Rapid Commun Mass Spectrom; 2006; 20(13):1981-8. PubMed ID: 16755608
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of liquiritigenin in mice, rats, rabbits, and dogs, and animal scale-up.
Kang HE; Jung HY; Cho YK; Kim SH; Sohn SI; Baek SR; Lee MG
J Pharm Sci; 2009 Nov; 98(11):4327-42. PubMed ID: 19226634
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of ipriflavone and its two metabolites, M1 and M5, after the intravenous and oral administration of ipriflavone to rat model of diabetes mellitus induced by streptozotocin.
Lee DY; Chung HJ; Choi YH; Lee U; Kim SH; Lee I; Lee MG
Eur J Pharm Sci; 2009 Dec; 38(5):465-71. PubMed ID: 19761842
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and first-pass effects of liquiritigenin in rats: low bioavailability is primarily due to extensive gastrointestinal first-pass effect.
Kang HE; Cho YK; Jung HY; Choi KY; Sohn SI; Baek SR; Lee MG
Xenobiotica; 2009 Jun; 39(6):465-75. PubMed ID: 19480552
[TBL] [Abstract][Full Text] [Related]
11. Distribution of liposomal bifendate in liver following intravenous injection in mice.
Zhipeng C; Jiabi Z; Hongxuan C; Yan-yu X; Jun C; Bao-chang C
J Drug Target; 2010 Sep; 18(8):627-36. PubMed ID: 20166805
[TBL] [Abstract][Full Text] [Related]
12. Effect of 2-methylaminoethyl-4,4'-dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2-carboxylic acid-2'-carboxylate monohydrochloride (DDB-S) on indocyanine green (ICG) clearance in rats.
Lee KJ; Kim JR; Lee CH
Arch Pharm Res; 2005 Jan; 28(1):115-9. PubMed ID: 15742819
[TBL] [Abstract][Full Text] [Related]
13. Liquiritigenin, a flavonoid aglycone from licorice, has a choleretic effect and the ability to induce hepatic transporters and phase-II enzymes.
Kim YW; Kang HE; Lee MG; Hwang SJ; Kim SC; Lee CH; Kim SG
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G372-81. PubMed ID: 19074639
[TBL] [Abstract][Full Text] [Related]
14. Effects of route of administration and blood flow on hepatic drug elimination.
Shand DG; Kornhauser DM; Wilkinson GR
J Pharmacol Exp Ther; 1975 Dec; 195(3):424-32. PubMed ID: 1195129
[TBL] [Abstract][Full Text] [Related]
15. Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of liquiritigenin and its two glucuronides, M1 and M2, in rats.
Kang HE; Sohn SI; Baek SR; Lee JW; Lee MG
J Pharm Pharmacol; 2011 Jan; 63(1):49-57. PubMed ID: 21155815
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism.
Lau YY; Okochi H; Huang Y; Benet LZ
Drug Metab Dispos; 2006 Jul; 34(7):1175-81. PubMed ID: 16624870
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic changes of DA-7867, a new oxazolidinone, after intravenous and oral administration to rats with short-term and long-term diabetes mellitus induced by streptozotocin.
Bae SK; Yang SH; Lee SJ; Kwon JW; Kim WB; Lee DC; Lee MG
Eur J Pharm Sci; 2005 Jun; 25(2-3):337-45. PubMed ID: 15911231
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of oltipraz in rat models of diabetes mellitus induced by alloxan or streptozotocin.
Bae SK; Kim JY; Yang SH; Kim JW; Kim T; Lee MG
Life Sci; 2006 Apr; 78(20):2287-94. PubMed ID: 16288785
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic interaction between 5-[2-propyloxy-5-(1-methyl-2-pyrollidinylethylamidosulfonyl)phenyl]-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo (4,3-d) pyrimidine-7-one (DA-8159) and nitroglycerin in rats.
Lee SJ; Bae SK; Kwon JW; You M; Lee DC; Lee MG
J Pharm Pharmacol; 2005 Nov; 57(11):1397-405. PubMed ID: 16259771
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of bicyclol in rats with acute hepatic failure.
Tan W; Wang B; Zhao J; Sheng L; Hu J; Li Y
Xenobiotica; 2008 Nov; 38(11):1399-409. PubMed ID: 18988083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
